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Summal~ 
In immature thymocytes, T  cell receptor for antigen (TCR)  mobilization leads  to an active 
T cell suicide process,  apoptosis, which is involved in the selection of the T cell repertoire. We 
have proposed that inappropriate induction of such a cell death program in the mature CD4 + 
T cell population could account for both early qualitative  and late quantitative CD4 + T lympho- 
cyte defects of human immunodeficiency virus (HIV)-infected individuals (Ameisen, J. C., and 
A. Capron.  1991. Immunol.  Today.  4:102).  Here, we report that the selective failure of CD4 § 
T cells from 59 clinically asymptomatic HIV-infected individuals to proliferate in vitro to TCR 
mobilization by major histocompafibility complex class II-dependent superantigens and to pokeweed 
mitogen (PWM)  is due to an active CD4 + T  cell death process,  with the biochemical and 
ultrastructural features of apoptosis. Activation-induced cell death occurred only in the CD4 + 
T cell population from HIV-infected asymptomatic individuals and was not observed in T cells 
from any of 58 HIV-seronegative controls, including nine patients with other acute or chronic 
infectious diseases.  Activation-induced CD4 + T  cell death was prevented by cycloheximide, 
cyclosporin A, and a CD28 monoclonal antibody (mAb). The CD28 mAb not only prevented 
apoptosis but also restored T cell proliferation to stimuli, including PWM, superantigens, and 
the tetanus and influenza recall antigens. These findings may have implications for the understanding 
of the pathogenesis of acquired immune deficiency syndrome and for the design of specific therapeutic 
strategies. 
H 
IV-infected individuals present early CD4 + T cell func- 
tional defects (1-7) that precede the quantitative reduc- 
tion in this cell population which leads to acquired immune 
deficiency syndrome (AIDS). These functional defects are de- 
tected while less than 1/1,000 helper T cells are infected (8-10), 
and are characterized by a selective loss of ability to proliferate 
in vitro to self-MHC class II-restricted recall antigens and 
to PWM (1-7), and the capacity to proliferate to the PHA 
mitogen is maintained. CD4 + T cell dysfunction and deple- 
tion have been attributed to a wide range of distinct mecha- 
nisms. In particular, the early qualitative defects have been 
related to T  cell suppression (7,  11), clonal anergia (7), au- 
toimmune responses (12), inhibitory effects of HIV proteins 
(13,  14), or selective HIV-mediated destruction of memory 
T cells, leading to the presence of only naive CD4 + T cells 
(15,  16). 
Part of this work has been presented  to the VII International  Conference 
on AIDS, Florence, Italy, 16-21 June 1991 (Abs:WA1235); and in a 
preliminary report to the French Science  Science  Academy  (C.R. Acad. 
Sci. Set. III Sci. Vie., Paris 1991, 312:599). 
Ameisen and Capron (17) have proposed the hypothesis 
that a single mechanism, the inappropriate reemergence of 
a T  cell death program in response to activation, could ac- 
count for both early qualitative and late quantitative CD4 + 
T  cell defects from HIV-infected individuals. Programmed 
cell death, activation-induced cell death, or apoptosis, is an 
active cell suicide mechanism of widespread biological im- 
portance (18) that constitutes the physiological response of 
normal immature thymocytes to activation (18-23).  This pro- 
cess is involved in the negative selection of the T cell reper- 
toire, which leads  to the clonal deletion of autoreactive T 
cells, and to the establishment of self-tolerance (24). This cell 
suicide mechanism occurs in the absence of bystander cell de- 
struction, requires cell activation, initiation of protein syn- 
thesis,  and  involves  the  activation  of an  endogenous  en- 
donuclease that results in a characteristic regular fragmentation 
of the entire cellular DNA into multiples of an oligonucleo- 
some unit of 200 bp (18-28). In immature thymocytes, apop- 
tosis is not an obligatory response to TCR stimulation, but 
is the consequence of incomplete signal transduction related 
to the nature of the antigen-presenting cell and to the ab- 
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in T  cell biology has been whether TC1K mobilization may 
also lead in some circumstances to the reemergence of a func- 
tional cell death program in mature T  cells. Recent studies 
involving mature murine T  cells indicate that this is indeed 
the case (31,  32). 
We have investigated whether in vitro activation of T cells 
from clinically asymptomatic HIV-l-infected individuals, in- 
cluding individuals with normal CD4 §  T  cell counts,  and 
from controls with polyclonal activators and self-MHC dass 
II-dependent recall antigens may lead to T  cell death. Since 
memory T  cells specific for a given recall antigen are rare, 
and might be depleted in HIVqnfected individuals, we also 
investigated the T cell response to the self-MHC class II-de- 
pendent staphylococcal enterotoxin B  (SEB) 1 superantigens 
(33), which had not been previously explored in HIV-infected 
individuals. These superantigens bind to MHC class II mol- 
ecules and interact with defined Vfl TCIK molecules expressed 
by up to 30%  of human T  cells, inducing proliferation in 
normal mature CD4 + T  cells (33) and apoptosis in imma- 
ture thymocytes (21). 
Materials  and Methods 
Study Subjects.  Peripheral blood was obtained from 109 HIV- 
infected asymptomatic individuals  in the Service des Maladies In- 
fectieuses,  Centre Hospitalier de Tourcoing, France.  Of 75 men 
and 34 women, all clinically asymptomatic (stage II of the Center 
for Disease Control [CDC], Atlanta, classification), 79 were CDC 
stage  IIA (no biological abnormalities,  CD4 >500/ram 3,  mean 
884) and 30 were CDC stage IIB (biological  abnormalities, CD4 
<500/ram 3, mean 342). HIV infection was related to homosexu- 
ality (n  =  49), heterosexual contact (n  =  30), intravenous drug 
use (n  =  28),  or blood transfusion (n  =  2).  Controls (n  =  58) 
were 49 HIV-seronegative healthy donors and nine HIV-seronegative 
patients with infectious or autoimmune diseases. These included, 
respectively: symptomatic infectious mononucleosis,  genital herpes, 
Candida albkans spondylitis,  cutaneous  staphylococcal  infection 
with staphylococcal septic arthritis in a diabetic patient, evolutive Loa 
loa filariasis, evolutive onchocercosis with eosinophilia,  falciparum 
malaria,  Gram-negative pneumopathy, and periarthritis nodosa. 
Cell Preparations.  PMBC were obtained on Ficoll-Hypaque, and 
cells were cultured as previously described (34). 
In some experiments, CD4 + or CD8 + T cells were purified by 
negative selection with magnetic beads coated by anti-mouse IgG 
(Dynal, Biosys, Compi~gne,  France). Cells (50  x  106) were plated 
to plastic petri dishes to harvest adherent cells by scraping. Nonad- 
herent cells were incubated with 5 #g/ml of CD20, CD56, MHC 
class II, CD4, or CD8 mAbs in a volume of 5 ml in RPMI for 
30 mn. Subsequently, excess antibody was removed by washing 
twice in RPMI. The cells were then resuspended in 5 ml RPMI 
with magnetic beads, according to the manufacturer's instructions. 
This mixture was rotated in the cold for 30 rain and the cells were 
passed through a magnetic field twice to remove the cells that had 
bound to the magnetic beads. Cells were 98% pure as assessed by 
cytofluorometry. 
1  Abbret,  iations used in this paper: CsA, cyclosporin  A; SEB, staphylococcal 
enterotoxin B; TT, tetanus toxoid. 
In some experiments, PBMC were depleted either in CD4 + or 
CD8 + T  cells by using the same general method, cytoftuorom- 
etry analysis revealing less than 2% contaminating cells. 
Cell Proliferation Assays.  Cell proliferation assays were performed 
in 96-well  culture plates  (Nunc,  Roskilde, Denmark) in  a final 
volume of 200/A,  as previously described  (34).  PBMC (2.5  x 
10S/ml) were cultured in RPMI/10% FCS. Mitogens (purchased 
from Sigma, La Verpilli~re, France) were used, respectively, at the 
following final concentrations: PHA, 10/~g/ml; Con A, 10 pg/ml; 
PWM, 10/~g/ml; staphylococcal enterotoxin B (SEB) superantigens, 
1/zg/ml; the CD3 mAb was used at 1/zg/ml. Tetanus toxoid (TT) 
recall antigen (Biomerieux, Lyon, France) was used at 10/~g/ml; 
and influenza A hemagglutinin (Infl) recall antigen (Eurobio, Paris, 
France) at 10 #g/ml. After 3 d for mitogens or 6 d for antigens, 
cultures  were  pulsed  with  1  /zCi  of [3H]thymidine  (1  or  25 
Ci/mmol,  depending on the experiments; Amersham, les Ulis, 
France)  during the final  15 h  of incubation, and harvested. 
Evaluation of Cell Death by Trypan Blue Exclusion.  Cells were 
incubated in 96-well plates with various stimuli in the same condi- 
tions as for proliferation assays. They were harvested by pipetting 
and diluted 1:2 with 0.1% trypan blue in PBS. The live and dead 
cells were counted in a hemocytometer. 
DNA Fragmentation Assays.  DNA fragmentation was deter- 
mined according to the methods of Wyllie and Morris (28),  and 
Newell et al.  (31), with slight modifications. In brief,  107 cells 
were collected by centrifugation at 200 g  for 10 rain,  and lysed 
in I ml hypotonic lysing buffer (5 mM Tris, pH 7.4, 5 mM EDTA, 
0.5% Triton )(-100). The lysates were centrifuged at 13,000 g for 
15 rain.  Supematants were deproteinized by extraction once in 
phenol/chloroform and twice in chloroform/isoamyl alcohol (24:1) 
and precipitated at  -20~  in 50% isopropanol, 130 mM NaC1. 
After electrophoresis on 2% agarose slab gels, DNA was stained 
by ethidium bromide. 
Electron Microscopy.  Cells were fixed in 1% glutaraldehyde in 
0.1 M sodium cacodylate buffer, pH 7.4, for 2 h at  +4~  Pellets 
were postfixed in 1% aqueous osmium tetroxide for 1 h, en bloc 
stained in 1% aqueous uranyl acetate for 6 h,  and embedded in 
araldite. Sections were stained with uranyl acetate and lead citrate 
before examination with a Philips (Mahwah, NJ) EM 420 electron 
microscope. 
Monoclonal Antibodies and Chemicals.  The mAbs used in this 
study were CD3 (X35-7, IgG2a), generous gift from Dr. Bourel, 
Centre R6gional de Transfusion Sanguine,  Rennes, France; CD28 
(9.3,  IgG2a), generous gift from Oncogen Corp., Seattle,  WA; 
CD28 (CLB 28/1, IgG1), purchased fromJanssen, Beerse, Belgium; 
CD20 (IOB20, IgM), CD56 (IOT56, IgG1), HLA-D1K (IOT2a, 
IgG2b), CD4 (IOT4, IgG2a), CD8 (IOT8, IgG2a), were all pur- 
chased from Immunotech, Marseille, France;  CD5 (AS0,  IgG1), 
CD44 (P245, IgG2a), generous gifts from Dr, A. Bernard, Centre 
Hospitalier  R6gional,  Nice,  France.  CsA  was  purchased  from 
Sandoz, 1Kueil-Malmaison, France; cycloheximide from Sigma, and 
azidothymidine (AZT) from Burroughs Wellcome, Paris, France. 
Statistical Analysis.  Statistical significance was assessed by using 
Student's t test. 
Results 
Proliferative Response of T  Cells from HIVinfected Asymp- 
tomatic Individuals and from Controls.  We investigated the in 
vitro proliferation of T  ceils from 109 HIV-infected asymp- 
tomatic individuals and 59 controls in response to the poly- 
clonal activators PHA,  Con A,  PWM,  CD3  mAb,  to the 
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Cell Death in PBMC and Purified T Cells from HIV-infected 
Asymptomatic Individuals  and  from Controls.  Cell viability was 
investigated in 59 of the 109 HIV-infected asymptomatic in- 
dividuals explored in the study.  Addition of PWM or SEB 
to PBMC from the 59 HIV-infected asymptomatic individ- 
uals was followed by cell death after 48 h of about 40% and 
20%, respectively,  of PBMC, whereas no cell death was ob- 
served at 48 h in the unstimulated PBMC from HIV-infected 
asymptomatic individuals.  No cell death was detected in the 
unstimulated  and  stimulated  PBMC  from  the  49  HIV- 
seronegative healthy controls (Fig. 2 A) and from the nine 
HIV-seronegative controls with acute or chronic infectious 
diseases  (Fig.  2 B). 
To identify the cell population undergoing cell death after 
activation, PBMC from 12 HIV-infected asymptomatic indi- 
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Figure 1.  Proliferative response of T  cells from HIV-infected asymp- 
tomatic individuals and from controls. (.4) Histograms represent the mean 
_  SD of measurement of [3H]thymidine incorporation of T cells from 
100 HIV-infected asymptomatic individuals (HIV-infected) and from 40 
HIV-seronegative healthy controls  (controls  I) incubated with medium 
alone, PHA (10 #g/ml), PWM (10 #g/ml), superantigens (SEB) (1 #g/ml), 
and the tetanus toxoid (TT) recall antigen (10 #g/ml). The specific ac- 
tivity of the [3H]thymidine used was 1 Ci/mmol. (B) Histograms  repre- 
sent the mean  _+ SD of measurement of [3H]thymidine incorporation of 
T cells from nine HIV-infected asymptomatic individuals (HIV-infected), 
from nine HIV-seronegative healthy controls (controls 1), and from nine 
HIV-seronegative patients suffering from acute or chronic infectious dis- 
eases (controls 2) incubated with medium alone, PHA, PWM, and SEB 
as described in A. The specific activity of the [3H]thymidine  used was 
25 Ci/mmol. 
tetanus recall antigen, and to the SEB superantigens.  T cells 
from all healthy controls proliferated  to all stimuli,  and T 
cells from HIVoinfected asymptomatic individuals showed a 
selective defect in their response to SEB,  to recall antigen, 
and to PWM  (Fig.  1 A). 
Proliferation of T  cells from HIV-infected individuals  to 
Con A  and to CD3  mAb  was only slightly  reduced (not 
shown),  as was proliferation to PHA (Fig.  1 A).  This was 
consistent  with  the  fact  that  all  HIV-infected  individuals 
studied were clinically asymptomatic,  with few or no bio- 
logical abnormalities,  since defective proliferations to CD3 
mAb and to PHA have been reported to be predictive markers 
of evolution towards AIDS in long-term infected individuals 
or patients  (35). 
As shown in Fig. 1 B, T cells from nine HIV-seronegative 
controls with acute or chronic infectious diseases  prolifer- 
ated less well to PHA than T cells from HIV-infected indi- 
viduals,  but better to PWM  and  to SEB. 
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Figure 2.  Cell death in PBMC from HIV-infected asymptomatic indi- 
viduals and from controls after in vitro culture with PWM and SEB. (.4) 
Histograms represent the mean  +_ SD of triplicate measurements of the 
percentage of cell death in PBMC from 50 different HIV-infected asymp- 
tomatic  individuals (I) and 40 controls  (2),  48 h after incubation  with 
medium alone, PHA (10 #g/ml), PWM (10 #g/m1), or SEB (1 #g/m1), 
in the absence or in the presence of cycloheximide (50 #g/ml), CsA (200 
ng/ml), or CD28 mAb (10/~g/ml).  Cell death was assessed by trypan 
blue permeability. (B) Histograms represent the mean +_ SD of triplicate 
measurements of the percentage of cell mortality in PBMC  from nine 
different HIV-infected asymptomatic individuals (HIV-infected), nine HIV- 
seronegative controls  (controls  1),  and nine HIV-seronegative  patients 
suffering from acute or chronic infectious diseases (controls 2), 48 h after 
incubation with medium alone, PHA, PWM, or SEB as described in A. 
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Figure 3.  Cell death in purified T cell populations  from HIV-infected 
asymptomatic  individuals  and from controls  after in vitro culture with 
PWM and SEB. (A) Histograms represent  the mean  _+  SD of triplicate 
measurement  of cell mortality in CD8 + T call- or CD4 + T cell-depleted 
PMBC from 12 HIV-infected asymptomatic  individuals (1) and 4 controls 
(2).  T  cell  proliferation  was  also  measured  by  [3H]thymidine  (25 
Ci/mmol) incorporation after 3 d; the CD8 + T cell-depleted PBMC from 
controls proliferated to PWM (16,828  _+ 4,247 cpm) and to SEB (31,327 
_+  8,624 cpm),  whereas neither the CD4 + T cell-depleted  PBMC from 
the control, nor the CD8 + or CD4+  T  cell-depleted  PBMC from the 
HIV-infected asymptomatic  individuals proliferated to either stimuli.  (B) 
Histograms represent  the mean  _+  SD of triplicate  measurement  of cell 
mortality in purified  (98%  pure)  CD4 + and  CD8 + T  cells from two 
HIV-infected asymptomatic  individuals  (I and 2) and a control (3). Per- 
centage of CD4 + T cells in unpurified  PBMC was 50% in individual  I, 
and  52%  in  individual  2.  T  cell  proliferation  was  also measured  by 
[3H]thymidine  (1 Ci/mmol) incorporation after 3 d; purified CD4 + and 
CD8 + T cells from HIV-infected individuals and from the control prolifer- 
ated  normally to  PHA.  CD4 + T  cells from control proliferated  in re- 
sponse to PWM (4,817  _+  351 cpm) and to SEB (21,892  _+  1,628 cpm), 
whereas  CD8 + T  cells from the control and CD4 + and CD8 + T  cells 
from the HIV-infected  individuals  did not proliferate  to either stimuli. 
viduals and four healthy controls were  depleted of either 
CD4 + T  cells or of CD8 + T  cells. After addition of PWM 
or SEB, cell death was observed only in the CD8 § T  cell- 
depleted PBMC population (containing the CD4 §  T  cell 
population) from HIV-infected asymptomatic  individuals (Fig. 
3 A),  suggesting that neither CD8 + T  cells, B cells,  nat- 
ural killer cells, nor monocytes underwent activation-induced 
cell death in the absence of CD4 § T cells. 98% pure CD4 + 
T  cells and CD8 + T  cells were also prepared from PBMC 
from two HIV-infected asymptomatic individuals and a con- 
Figure 4.  Apoptosis  of T cells from HIV-infected asymptomatic  indi- 
viduals in response to PWM or SEB. (a) DNA fragmentation  in PBMC 
from HIV-infected asymptomatic  individuals and controls after overnight 
incubation  with medium alone, PWM (5 #g/m1),  or SEB (1 #g/ml) in 
the absence or presence of CsA (200 ng/ml) or CD28 mAb. DNA weight 
markers (lane I); control PBMC with PWM (lane 2); PBMC from eight 
HIV-infected asymptomatic  individuals  with: medium (lanes 3 and 12), 
PWM (lanes 4-9 and 13), or SEB (lanes 10 and  11). Lanes 3 and 4 and 
12-14 show cells from the same individuals. Lanes 4-6, 8-11, and 13 show 
a clear ladder of degraded DNA bands which are multiple of 200 bp, char- 
acteristic for apoptosis (10-13 and 17-19). DNA fragmentation  was sup- 
pressed when CsA (lane 7, cells from same individual as lane 6) or CD28 
mAb (lane 14, cells from same individual as lane I3) was added to PWM. 
(b and c) Electron micrographs of PBMC from a HIV-infected asymptom- 
atic individual  after 24 h of incubation  with (b) medium or (c) PWM (5 
#g/ml). Cells showing various stages of chromatin condensation,  charac- 
teristic for apoptosis (10, 17, 19, 20), can be seen in (c) (arrows). Bars = 5 ~m. 
trol. As shown in Fig. 3/3, activation-induced cell death in 
response to PWM or SEB was only observed  in the CD4 + 
T lymphocyte  population from the two HIV-infected asymp- 
tomatic individuals. The percentages of cell death induced 
by PWM stimulation (% PWM-induced death  -  % back- 
ground death in medium) were 45% and 52%, respectively, 
in the purified CD4 + T  cell populations of the two HIV- 
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and Death of T  Cells from HIV-infected Asymptomatic 
Individuals and Controls 
Proliferation  Mortality 
Medium  PWM  PHA  Medium  PWM  PHA 
cpm  ~o 
Patient  A  180  3,604  44,567  7  34  7 
+  AZT  152  2,846  46,567  10  32  6 
Patient  B  395  2,138  51,299  6  28  5 
+  AZT  432  3,027  47,321  7  31  6 
Patient  C  204  1,873  17,556  6  23  5 
+AZT  396  1,846  19,122  5  29  7 
Patient  D  818  2,491  25,284  4  38  5 
+  AZT  396  3,936  33,336  5  36  4 
Control A  321  13,227 17,754  6  5  6 
+  AZT  244  12,521 14,081  4  6  5 
Control B  467  18,532  37,317  5  4  7 
+  AZT  383  21,123  34,821  6  5  7 
Results represent mean -+ SD of triplicate measurements of [3H]thymi- 
dine incorporation  of PBMC and the percentage  of cell mortality  at 48 h 
from four HIV-infected  asymptomatic  individuals and from two controls 
in response to medium alone, PHA, and PWM in the presence or ab- 
sence of 10 -5 M of AZT. At 10 -5 M, AZT inhibited syncitia forma- 
tion in the MT2 CD4 + T cell line infected with 100  x  TCID 50 of 
a purified preparation of the HTLV-IIIB strain of HIV-1. 
infected individuals. Since activation-induced cell death was 
only observed in the CD4 § T cell population, and since the 
percentages of CD4 + T  ceils present in unpurified PBMC 
were, respectively, 50 and 52%,  one would expect around 
22  and 27%  of cell death in PWM-stimulated unpurified 
PBMC. These percentages are close to the 27 and 30% actu- 
ally observed. In superantigen-stimulated unpurified PBMC, 
expected percentages of cell death were 9 and 10%, and ob- 
served percentages were 10 and 14%.  Thus,  slightly more 
cells died in the stimulated unpurified PBMC than in the 
purified stimulated CD4 + T cell populations. This suggests 
either that stimulation of the whole PBMC population leads 
to  more CD4 §  T  cell death,  or alternatively that,  when 
CD4 §  T  cells  are present,  a  fraction of cells  other  than 
CD4 § T lymphocytes also undergo activation-induced  death. 
Mechanism and Prevention of T Cell Death.  Death of T cells 
from HIV-infected asymptomatic individuals involved two 
features chara.cteristic  of apoptosis (18-21, 25-28, 36). First, 
gel electrophoresis of the DNA of PBMC from HIV-infected 
asymptomatic individuals, performed 18 h after addition of 
PWM or SEB, showed a DNA fragmentation pattern in mul- 
tiples of a 200-bp oligonucleosome length unit (Fig.  4 a). 
Second, electron microscopy of PBMC from HIV-infected 
asymptomatic individuals 18 h after the addition of PWM 
revealed nuclear chromatin condensation (Fig.  4 c). 
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Figure 5.  Effect  of CD28 mAb on the proliferative  response  of T cells 
from HIV-infected  asymptomatic  individuals. Circles represent  the mean 
_+ SD of triplicate  measurement of [3H]thymidine  incorporation  of T ceils 
from (a) each of 19 HIV-infected  asymptomatic  individuals  incubated  with 
PW.M, SEB, TT, or medium alone, in the absence (0) or presence (O) 
of CD28 mAb (specific  activity  of [3H]thymldine  used, 1 Ci/mmol), and 
from (b) each  of 15 HIV-infected  asymptomatic  individuals  incubated  with 
PWM, SEB, TT, or medium alone, in the absence (Q) or presence (O) 
of CD28 mAb (specific  activity of [3H]thymidine  used, 25 Ci/mmol). 
Certain circles  representing  similar values  are superimposed. *p < 0.00004. 
Activation-induced T cell death appeared unrelated to HIV- 
mediated cytopathogenic effects. Indeed, first, electron mi- 
croscopy of PWM- or SEB-activated PBMC did not reveal 
the presence of HIV viral particles.  Second, as shown in Table 
1, activation-induced cell death in PBMC from HIV-infected 
asymptomatic individuals was not modified in the presence 
of the reverse transcriptase inhibitor azidothymidine (AZT), 
a concentration that prevented syncitia formation in the MT2 
CD4 § T  cell line when added together with 100  x  TCID 
50 of the HTLV-IIIB stain of HIV-1 (Table  1). 
An essential characteristic of apoptosis in various cell popu- 
lations is its dependence on cell activation, gene transcrip- 
tion, and protein synthesis in the dying cell (25-27; reviewed 
in reference 18). Addition of the protein synthesis inhibitor 
cycloheximide, or of cydosporin A (CsA), both of which pre- 
vent activation-induced apoptosis in immature thymocytes 
(20), prevented activation-induced death by apoptosis of T 
cells from HIV-infected asymptomatic individuals  in response 
to PWM  and SEB (Fig.  2 A,  and Fig.  4 a,  lane  7). 
Restoration of the Capacity of CD4 + T  Cells To Proliferate 
to  Stimuli.  Protein  synthesis  inhibitors  and  CsA,  which 
prevented apoptosis, also prevented T cell proliferation in re- 
sponse to stimuli.  It has been shown in immature thymo- 
cytes that the addition of certain cosignals such as IL-1, ILo2, 
and phorbol esters not only prevent apoptosis, but also allow 
a proliferative response to stimuli (22, 24, 29, 30). Addition 
335  Groux  et al. to T cells from HIV-infected asymptomatic individuals of IL-1, 
IL-2, or phorbol esters  neither prevented apoptosis nor al- 
lowed proliferation in response to PWM or SEB (not shown). 
The CD28 mAb cosignal, that enhances the stability and tran- 
scription of several lymphokine mRNAs (37, 38) in normal 
mature activated CD4 § T  cells, has been reported to allow 
proliferation of normal immature thymocytes to stimuli (39), 
and to enhance in T cells from HIV-infected individuals the 
proliferative response to the CD3 antibody (15). As shown 
in Figs. 2 A, 3 B, and 4a (lane 14), addition of CD28 mAb 
to  PBMC  or  purified  CD4 +  T  cells  from  HIV-infected 
asymptomatic individuals  prevented PWM- and SEB-induced 
death by apoptosis and, as shown in Fig. 5, also restored T cell 
proliferation in response to PWM and SEB. CD28 mAb alone 
did not  induce proliferation of T  cells  from HIVoinfected 
asymptomatic individuals (Fig. 5), and CD28 mAb did not 
enhance control T  cell proliferation to PWM, SEB, or TT. 
CD28 mAb restored proliferation to PWM and SEB of  purified 
CD4 + T  cells, but not of purified CD8 + T  cells from an 
HIV-infected asymptomatic individual  (not  shown).  Two 
different CD28 mAb (CLB28/1, IgG1, and 9.3, IgG2a isotype) 
were used  and  had  the  same  effect, while control mAbs 
of the same isotype (CD5,  IgG1,  and CD44,  IgG2a) had 
no effect. 
As shown in Fig. 5, CD28 mAb not only restored prolifer- 
ation of T cells from HIV-infected individuals to PWM and 
SEB, but also  to the tetanus recall antigen, indicating that 
tetanus-specific memory T  cells were present in the HIV- 
infected individuals,  and suggesting that in vitro antigen- 
mediated induction of apoptosis might account for their in 
vitro proliferative defect to the recall antigen. 
Antigen-mediated  Functional Deletion  of Antigen-specific  T 
Cells.  Whether antigen may induce selective in vitro dele- 
tion of specific  memory T  cells  was  further investigated. 
PBMC from four HIV-infected asymptomatic individuals and 
from two controls were first incubated for 10 d with the tetanus 
antigen in the absence of CD28 mAb. At day 10, cell death 
was 12-15% in PBMC from HIV-infected asymptomatic in- 
dividuals and from controls. As shown in Table 2, cells were 
then layered on FicoU/Hypaque, washed twice, and incubated 
for 3 d with PHA or for 6 d with the tetanus or the influenza 
recall antigens, in the absence or presence of the CD28 mAb. 
Cells from HIV-infected asymptomatic individuals that had 
been treated first with tetanus recall antigen retained their 
capacity to proliferate to the influenza recall antigen in the 
presence of CD28 mAb, but selectively lost their subsequent 
capacity to proliferate to tetanus in the presence of CD28 
mAb,  suggesting that tetanus-specific memory T  cells had 
been selectivity deleted during the first incubation with the 
tetanus antigen. As also shown in Table 2, preincubation of 
PBMC from controls with the tetanus antigen did not lead 
to any subsequent functional impairment. 
Table 2.  Antigen-mediated Functional Deletion of Antigen-specific Memory T  Cells from HIV-infected Asymptomatic Individuals 
Before stimulation  with: 
Preincubation  Medium  CD28  TT  TT + CD28  Intl.  Intl.  +  CD28  PHA 
c~m 
HIV§  No preincubation  121  _+  52  314  +  87  236  +  78  2,617  _+  321  341  _+  58  3,217  +  206  18,621  _+  817 
with  TT  614  _+  87  258  _+  94  318  _+  97  415  _+  87  721  _+  75  6,731  _+  345  17,182  _+  751 
HIV§  No preincubation  447  _+  34  313  _+  57  317  _+  27  5,736  _+  187  151  _+  57  3,842  +  137  17,980  _+  243 
withTT  221  +_  67  318  +  61  176  +  50  118  +  21  345  _+  46  5,351 +  142  16,441 _+  419 
HIV§  No preincubation  324  _+  38  249  +  64  437  _+  31  3,781  +  108  438  _+  51  6,242  +  107  28,143  _+  243 
withTT  479  +_  61  408  _+  37  459  _+  61  438  +  71  386  -+  48  2,674  +  157  24,597  _+  267 
HIV§  No preincubation  350  _+  217  405  +  104  157  +_  117  1,549 _+  817  108  _+  64  1,560  _+  258  28,232  _+  6,712 
with TT  103  +  37  207  _+  83  483  _+  121  342  _+  106  435  +  265  2,170  +_  598  23,315  _+  4,612 
Control 1  No preincubation  680  +  217  354  _+  70  3,930  +  881  3,290  +  721  2,314  _+  567  3,254  _+  432  31,217  _+  2,642 
with TT  569  _+  258  208  +  62  7,091  _+  932  4,382  _+  792  2,090  _+  589  1,850  +  678  27,218  _+  4,812 
Control 2  No preincubation  477  _+  81  387  +  73  4,830  +  523  4,087  +  238  5,721 _+  267  4,239  _+  540  20,587  +  267 
with TT  297  _+  54  579  +  69  5,761 +  287  5,983  +  345  3,549  _+  138  4,820  _+  534  31,589  _+  354 
Ikesults represent  mean  _+  SD of triplicate  measurements  of [3H]thymidine  incorporation of PBMC from four HIV-infected asymptomatic  individu- 
als and from two controls.  Results  showing functional deletion are underlined.  Preincubation  with TT: PBMC (2.5  x  106/ml were cultured  for 10 d 
with the tetanus  recall antigen (TT) (10/.tg/ml). Cells were then incubated  with different  stimuli, and proliferation  measured  by [3H]thymidine 
incorporation after 3 d for PHA or PWM, and 6 d for TT or influenza A (Intl.)  recall antigens  (10/~g/ml), in the presence or absence of CD28 
mAb (10/~g/ml). 
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Our results support the hypothesis (17) that the selective 
in  vitro  proliferative  defect  of CD4 +  T  cells  from  HIV- 
infected asymptomatic individuals to TCR mobilization by 
self-MHC class II-dependent  superantigens,  and to PWM, 
is  related  to  the  induction  by  these  stimuli  of an  active 
CD4 + T cell death process by apoptosis. Cell death was not 
observed in the absence of stimuli nor in response to stimuli 
that induced proliferation  (PHA and the CD3 mAb).  Cell 
death did not occur in mononuclear cells depleted in CD4 § 
T  lymphocytes, and was observed in purified CD4 + T  cell 
populations,  suggesting that the presence of CD4 § T  cells 
was both necessary and sufficient for the induction  of this 
cell death process. No cell death was detected in stimulated 
or unstimulated  T  cells from 49 healthy HIV-seronegative 
controls, nor from nine HIV-seronegative patients with var- 
ious acute or chronic infectious diseases.  Although  CD4 § 
T cells from HIV-infected individuals failed to proliferate to 
TCR mobilization by the self-MHC class II-dependent tetanus 
and influenza  recall  antigens,  activation-induced  CD4 + T 
cell death in response to these antigens could not be detected. 
This is consistent with the fact that memory T cells specific 
for a given recall antigen are rare and that activation-induced 
cell death spares bystander cells (18), but could also be related, 
as  previously  suggested,  to  an  early  in  vivo depletion  of 
antigen-specific memory T cells (15, 16). We observed how- 
ever that  addition of a CD28 mAb cosignal that prevented 
apoptosis and restored T cell proliferation in response to PWM 
and to superantigens, also restored T cell proliferation to the 
tetanus and influenza recall antigens, indicating thus that the 
specific memory T cells were present in HIV-infected asymp- 
tomatic individuals. Preincubation of T cells with the tetanus 
antigen  in the absence of CD28 mAb led to a subsequent 
selective loss of their capacity to proliferate to this antigen 
in the presence of the antibody, while the T cell proliferative 
response to the influenza antigen in the presence of CD28 
was  not  impaired.  This  suggested  that  antigen-specific 
activation-induced  CD4 + T  cell death was the mechanism 
most likely to account for the failure of the memory T cells 
to proliferate  to these recall  antigens. 
After our work was completed and submitted for publica- 
tion,  two independent  reports  (40,  41)  also suggested the 
existence of a relationship between HIV-1 infection and apop- 
tosis. One study (40) showed that in vitro activation of PBMC 
from HIV-infected individuals with calcium ionophore leads 
in 24 h to death by apoptosis of a significant proportion of 
cells  that were not characterized.  That  study also reported 
spontaneous death by apoptosis of PBMC from HIV-infected 
individuals  after a 3-d incubation in the absence of any stimuli. 
Our assays, which were all performed after a 2-d incubation, 
showed the absence of spontaneous cell death in unstimu- 
lated PBMC from all  59 HIV-infected asymptomatic indi- 
viduals tested. Additional vital dye exclusion assays that we 
performed in PBMC from 18 HIV-infected asymptomatic in- 
dividuals did not reveal cell death after 3 d of incubation in 
the absence of stimuli.  We do not know whether this dis- 
crepancy may be related to differences in cell culture condi- 
tions, or to the biological or clinical  status of HIV-infected 
individuals  tested. 
The other report,  which does not concern T  cells from 
HIV-infected individuals, shows that the in vitro cytopatho- 
genic effect of some HIV-1 strains,  which follows in vitro 
HIV-1 infection of T cell lines or mononuclear cells, is related 
to the induction of apoptosis (41).  In HIV-infected asymp- 
tomatic  individuals,  less  than  0.1%  of peripheral  blood 
CD4 + T  cells are infected (8-10).  Therefore,  since we ob- 
served that in vitro activation with PWM resulted in the deaths 
of '~40%  of the CD4 + T  cells,  the possibility that  apop- 
tosis occurred only in HIV-infected CD4 + T  cells appeared 
most unlikely.  This was confirmed by electron microscopy 
studies revealing the absence of viral particle production, and 
by in vitro experiments performed in the presence of the re- 
verse transcriptase inhibitor AZT, showing that AZT did not 
affect activation-induced  T  cell death. 
The  recent  observations of apoptosis in  mature  murine 
CD4 § T  cells (31, 32) suggest at least two indirect mecha- 
nisms that may account for the reemergence in the mature 
CD4 + T  cell population of an activation-induced death pro- 
gram.  First,  CD4 § T  cells  from HIV-infected asymptom- 
atic individuals may be primed in vivo for apoptosis upon 
further activation. Pretreatment of mature murine CD4 + T 
cells with CD4 antibody has been shown to prime them for 
apoptosis upon selective mobilization of their TCR-o~/~ but 
not of their CD3 complex (31),  a response resembling that 
of CD4 + T  cells  from HIVoinfected individuals.  Obvious 
candidates for such an in vivo priming include the binding 
to CD4 of secreted HIV-gp120 envelope protein released in 
serum or lymph (42), gp120-anti-gp120  antibody immune 
complexes, or anti-CD4  autoantibodies.  However, prelimi- 
nary results obtained in our laboratory suggest that the sole 
preincubation of normal mature human CD4 + T  cells with 
CD4 antibody or gp120, whether crosslinked or not,  does 
not lead to apoptosis upon further  stimulation. 
A  second possibility is  that  CD4 +  T  cells  from  HIV- 
infected asymptomatic individuals have no intrinsic  abnor- 
malities, but that defective antigen-presenting  cell function 
accounts for induction of T cell apoptosis. Whether antigen- 
presenting cells from HIV-infected individuals are unable to 
provide relevant cosignals required for a proliferative response 
to PWM, or to MHC class II-dependent TCR mobilization, 
is currently under investigation.  It has been shown that re- 
stimulation of a mature murine CD4 + T cell done by cross- 
linked CD3 antibodies in the absence of antigen-presenting 
cells results in an active cell death process that involves INF-% 
and is prevented by anti-INF-3~  antibody (32). Our prelimi- 
nary data indicate that anti-INF-~ antibody does not prevent 
activation-induced death of CD4 + T cells from HIV-infected 
individuals. 
A third possible interpretation of our findings, which cannot 
be completely excluded, is that apoptosis is the consequence 
of a CD4 § T  cell/CD4 § T  cell-killing process. Induction 
of apoptosis in their target cells is one of the means by which 
CTL kill their targets (18, 43). Although cytotoxic proper- 
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T  cells, CD4 + CTL clones have been described (43).  Since 
CsA, which does not prevent CD8 § CTD or CD4 + CTL- 
mediated apoptosis of target cells (43),  prevented apoptosis 
of CD4 + T cells from HIV-infected asymptomatic individ- 
uals, we think that an activation-induced CD4 § T cell sui- 
cide process,  in the absence of any participation of CD4 + 
killer T cells, represents the simplest explanation for our ob- 
servations  at this stage. 
Our findings suggest the possibility that activation-induced 
T  cell death might also occur in vivo and account for the 
progressive  depletion of CD4 + T  cells that leads to AIDS 
(17).  This  implies  that  the rate  of in  vivo CD4 §  T  cell 
depletion might directly depend on the percentage of acti- 
vated T  cells and not on the percentage of HIV-infected T 
cells. In fact, since CD4 § T  cell activation is required for 
HIV-provirus integration (44),  and since activation will re- 
sult in a rapid cell deletion process by apoptosis,  apoptosis 
could also account for the very low percentage of HIV-infected 
T  cells in HIV-infected individuals. 
We have observed that the CD28 mAb prevents apoptosis 
and allows in vitro proliferation of memory T cells to recall 
antigens. Therefore, in vitro proliferation assays of CD4 § T 
cells in response to various recall antigens in the presence of 
CD28 mAb should allow to assess the extent of the memory 
CD4 §  T  cell  repertoire  that  is remaining in vivo at  any 
given time. This should allow to test whether CD4 § T cells 
specific for pathogens continuously present in HIV-infected 
individuals, such as HIV itself, herpes virus, or cytomegalo- 
virus, disappear  earlier in vivo than CD4 + memory T cells 
specific for pathogens that have been rarely (influenza) or never 
(tetanus) encountered subsequent to HIV infection. How- 
ever, additional mechanisms may lead to a progressive  en- 
hancement of antigen-mediated T call loss in vivo. First, once 
T cell clones specific for a given pathogen are depleted, the 
persistence  of the pathogen may progressively lead to the 
recruitment and deletion of low-affinity crossreactive T cell 
clones,  that are specific for other antigens. Second,  superin- 
fection by pathogens that express superantigens, such as staph- 
ylococcus, streptococcus,  or mycoplasma (45), could induce 
the deletion of a large number of CD4 + T cells expressing 
the matching V3 molecules, independent of their antigen 
specificity. Since murine retroviruses have been recently shown 
to encode superantigens (46), one cannot exclude the possi- 
bility that HIV itself might lead to the expression  of mole- 
cules with similar properties during the course of the disease. 
Our observation that CsA and the CD28 mAb prevent 
activation-induced  death of CD4 § T cells from HIV-infected 
asymptomatic individuals, and that CD28 mAb also restores 
their proliferative  response  to stimuli, might have implica- 
tions for the design of specific therapeutic strategies aimed 
at the prevention of AIDS. Animal models of AIDS-related 
diseases should allow testing the potential beneficial  effect 
of early in vivo correction of CD4 § T cell apoptosis on the 
further evolution of CD4 § T cell counts, and on the course 
of the disease. 
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